Mar 9 • 02:00 UTC 🇧🇷 Brazil Folha (PT)

Trump's Order Protected Potentially Cancer-Causing Herbicide and War Weapon

Donald Trump's recent executive order mandated the production of glyphosate, raising health concerns regarding its links to cancer while also prioritizing the production of military-grade phosphorus used in munitions.

In a surprising move, President Donald Trump issued an executive order requiring the production of glyphosate, a herbicide widely criticized for its potential cancer links. Activists have long campaigned against glyphosate, notably the Roundup product, urging a ban due to emerging health data linking it to cancerous effects. The announcement has reignited public debates about chemical safety and regulatory practices concerning pesticide approvals and health safeguards.

However, overshadowed by the controversies surrounding glyphosate, Trump's order also notably emphasized the priority manufacturing of military-grade phosphorus. Bayer, the company that manufactures glyphosate, is also the sole producer of elemental white phosphorus in the United States, a substance used not just in herbicide production but also in creating munitions for military purposes. White phosphorus is known for its incendiary properties, often used in military operations, raising further ethical and safety discussions about weapon production in the context of agricultural chemical manufacturing.

The decision to prioritize Bayer's operations, particularly regarding phosphorus, reflects a significant intersection between agricultural regulation and national security. The implications of this decision may extend beyond agriculture, impacting discussions regarding chemical safety, military supplies, and the broader conversation on public health. As activists continue to fight against glyphosate's detrimental health impacts, the dual focus on agricultural and military production underlines a complex balancing act for government policymakers amid ongoing debates about corporate influence and public safety regulations.

📡 Similar Coverage